7th Aug 2023 10:38
Arix Bioscience PLC - venture capital company focused on investing in breakthrough biotechnology companies - Reports a net asset value per share of GBP1.84 as at July 31, down from GBP1.86 as at June 30. Listed portfolio value falls to GBP69 million as at July 31 from GBP71.2 million as at June 30.
Current stock price: 117.25 pence, up 0.6% in London on Monday morning
12-month change: up 5.2%
By Heather Rydings, Alliance News senior economics reporter
Comments and questions to [email protected]
Copyright 2023 Alliance News Ltd. All Rights Reserved.